Aktueller Stellenwert der kontrastverstärkten Echokardiografie

Zusammenfassung

Die Echokardiografie mit lungengängigen Ultraschallkontrastmitteln stellt eine gut etablierte Methode dar, um die Limitationen der nicht kontrastverstärkten Echokardiografie infolge von Artefakten oder eines eingeschränkten Schallfensters zu minimieren. Es werden die aktuellen Empfehlungen zum Einsatz von lungengängigen Kontrastmitteln bei der regionalen Wandbewegungsanalyse, der Messung der Ejektionsfraktion, bei Thromben und Tumoren sowie bei der Perfusionsechokardiografie dargestellt.

Abstract

Contrast enhanced echocardiography using ultrasound enhancing agents (UEA) is a well-established method to overcome the limitations of unenhanced echocardiography due to artefacts or an impaired acoustic window. Current recommendations are summarized regarding the application of UEA for regional wall motion analysis, measurement of ejection fraction, detection of thrombi and tumors as well as myocardial contrast echocardiography.

Schlüsselwörter

Echokardiografie - Kontrastmittel - linksventrikuläre Funktion - mechanischer Index - Perfusionsechokardiografie

Key words

echocardiography - contrast agents - left ventricular function - mechanical index - MCE

• Literatur

• 1 Bommer WJ, Shah PM, Allen H. et al. The safety of contrast echocardiography: Report of the committee on contrast echocardiography for the American Society of Echocardiography. J Am Coll Cardiol 1984; 3: 6-13 doi:10.1016/S0735-1097(84)80423-4
• 2 European Medicines Agency. Optison: EPAR – Product Information. Im Internet: https://www.ema.europa.eu/documents/product-information/optison-epar-product-information_en.pdf Stand: 12.12.2019
• 3 European Medicines Agency. SonoVue: EPAR – Product Information. Im Internet: https://www.ema.europa.eu/documents/product-information/sonovue-epar-product-information_en.pdf Stand: 12.12.2019
• 4 European Medicines Agency. Luminity: EPAR – Product Information. Im Internet: https://www.ema.europa.eu/documents/product-information/luminity-epar-product-information_en.pdf Stand: 12.12.2019
• 5 Porter TR, Mulvagh SL, Abdelmoneim SS. et al. Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. J Am Soc Echocardiogr 2018; 31: 241-274 doi:10.1016/j.echo.2017.11.013
• 6 Senior R, Becher H, Monaghan M. et al. Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. Eur Heart J Cardiovasc Imaging 2017; 18: 1205-1205af doi:10.1093/ehjci/jex182
• 7 Becher H, Helfen A. Contrast Echocardiography. Compendium for clinical Practice. Berlin: Springer; 2019
• 8 Lang RM, Badano LP, Mor-Avi V. et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16: 233-271 doi:10.1093/ehjci/jev014
• 9 Malm S, Frigstad S, Sagberg E. et al. Accurate and Reproducible Measurement of Left Ventricular Volume and Ejection Fraction by Contrast Echocardiography: A Comparison With Magnetic Resonance Imaging. J Am Coll Cardiol 2004; 44: 1030-1035 doi:10.1016/j.jacc.2004.05.068
• 10 Hoffmann R, von Bardeleben S, Barletta G. et al. Comparison of Two- and Three-Dimensional Unenhanced and Contrast-Enhanced Echocardiographies Versus Cineventriculography Versus Cardiac Magnetic Resonance for Determination of Left Ventricular Function. Am J Cardiol 2014; 113: 395-401 doi:10.1016/j.amjcard.2013.09.038
• 11 Bulluck H, Chan MHH, Paradies V. et al. Incidence et al Predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis. J Cardiovasc Magn Reson 2018; 20: 72 doi:10.1186/s12968-018-0494-3
• 12 Knuuti J, Wijns W, Saraste A. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2019;
• 13 Helfen A, Eschenhagen S. Echokardiografie als Gatekeeper bei KHK. Aktuel Kardiol 2016; 5: 399-403 doi:10.1055/s-0042-115302
• 14 Wiegers SE, Ryan T, Arrighi JA. et al. 2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography). J Am Coll Cardiol 2019; 74: 377-402 doi:10.1016/j.jacc.2019.02.003